Office of Research and Project Administration
Northeast Biodefense Center FUNDING INFORMATION
Request for Proposals
NBC American Recovery and Reinvestment Act Supplement
Issue Date: April 14, 2009
Application Deadline:
5 pm EST May 12, 2009 (electronic copy);
5 pm EST May 14, 2009 (hard copies)
Approximate Award Date, June, 2009
Purpose
The NBC is eligible to receive support from the recently signed American Recovery and Reinvestment Act (ARRA). All areas of investigation that are suitable for RCE funding (as outlined in the RFA AI-08-002) are eligible for support with these funds including proof of principal work, product oriented studies, and basic research.
To qualify for support through the ARRA, projects must be exceptionally innovative. The research must demonstrate that it is of high risk but has the potential for high payoff if successful. It is expected that while these “out of the box” projects entail greater than the usual degree of scientific risk, they hold the potential for delivering transformational results or paradigm shifts. While the funding for these projects will terminate no more than two years after the award, it is expected that many of them will be able to continue with support from other sources.
Eligibility
The Principal Investigator must reside within HHS Region II. Collaborators may reside outside the region. Foreign components are not allowed. Previous experience in the fields of biodefense or emerging infectious diseases is not required, and there is no requirement that the proposed research align with the thematic goals of the NBC. Proposals that were previously included in applications in response to RFA AI-08-002 are not eligible, and existing RCE projects may not be supplemented. Minorities, women and individuals with disabilities are encouraged to apply.
Award Specifics
A project should request a minimum of $200,000 in direct costs per year for one or two years. All funds must be spent by the end of the award period. No clinical trials will be supported, and any involvement of human subjects must not entail more than minimal risk.
Application Process
Application deadline for electronic receipt is May 12, 2009. Hard copies must be received by May 14, 2009
Please use current NIH PHS-398 forms available at http://grants.nih.gov/grants/funding/phs398/phs398.html , and include only the following:
- Form Page 1: Face Page, institutional signatures not required. If the application is selected for award, we will request formal institutional signatures at that time. Dates of proposed period of support should be one or two years starting June 2009.
- Form Page 2: Summary, Relevance, etc.
- Form Page 4: Detailed Budget for Initial Funding Period.
- Form Page 5: Budget for Entire Period (up to 2 years) and justification
- Biographical Sketch and Research Support for all Key Personnel
- Research Plan (5 pages maximum) : Include Specific Aims, Background and Significance, Preliminary Studies (not required), and Research Design/Methods. ***Clearly identify why the proposed research is highly innovative and addresses major challenges.***
- Include Protection of Human Subjects, Targeted/Planned Enrollment Tables, Vertebrate Animals, and Select Agent Research/Biohazard sections, as appropriate. Projects with inadequate sections addressing protection of human subjects or use of vertebrate animals will not be considered.
- Checklist
Five (5) hard copies of the application should be sent to the address below.
Dr. Diane McFadden
Columbia University
722 West 168 th Street
Room 1715A
New York, NY 10032
Also, please email an electronic v ersion, as a PDF, to:
Dr. Diane McFadden at dcm2120@columbia.edu
For further information, please contact:
Dr. Diane McFadden
212-342-0007
dcm2120@columbia.edu
Please note:
The
The research areas that are included in the focus of the RCEs are described in RFA 08-002
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-08-002.html
